加载中
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
前收盘价
US$6.59
−US$0.03 · -0.45%
盘前
US$6.45
−US$0.14 · -2.12%
10月12日 4:26 ET
盘中时间采用ET。市场数据可能有所延迟。
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
日内区间
当前US$6.59
52周区间
当前US$6.59
盘中时间采用ET。市场数据可能有所延迟。
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
日内区间
当前US$6.59
52周区间
当前US$6.59
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 |
|---|---|---|---|
| 营收 | 1355.4万 USD | 1175.6万 USD | 975.3万 USD |
| 销货成本 | 638.1万 USD | 537.9万 USD | 426.2万 USD |
| 毛利 | 717.3万 USD | 637.7万 USD | 549.1万 USD |
| 研究与开发 | 1831万 USD | 1512万 USD | 933.3万 USD |
| 销售、一般及管理费用 | 1437.9万 USD | 1117.4万 USD | 750.5万 USD |
| 营业费用 | 3268.9万 USD | 2629.4万 USD | 1683.8万 USD |
| 利息收入 | 26.9万 USD | 2.6万 USD | 4.9万 USD |
| 折旧和摊销 | 56.7万 USD | 52.1万 USD | 38.8万 USD |
| 营业利润 | −2551.6万 USD | −1991.7万 USD | −1134.7万 USD |
| 净利润 | −2531.5万 USD | −1989.8万 USD | −1130.5万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$9.00
上涨空间 36.57%报告持有此股票敞口的交易所交易基金。
iShares Russell 2000 ETFIWM571.45万0.01%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI540.32万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 Growth ETFIWO216.03万0.02%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO116.8万0.01%180亿 USD0.06%US$112.66+0.50%
iShares Micro-Cap ETFIWC72.4万0.06%13.17亿 USD0.60%US$183+0.11%
Vanguard Extended Market ETFVXF58.97万0.00%954亿 USD0.05%US$235+0.80%
Vanguard Russell 2000 Growth ETFVTWG22.62万0.01%17亿 USD0.06%US$260.49+0.91%
iShares Russell 2500 ETFSMMD12.02万0.00%40.62亿 USD0.23%US$86.29+0.38%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCVanguard Extended Market ETFVXFVanguard Russell 2000 Growth ETFVTWGiShares Russell 2500 ETFSMMDAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
